Lipid Nanoparticles Archives -

Yesterday, the biotechnology company Capstan Therapeutics launched with $165 million in seed and Series A funding for it

CapstanTx secures $165 million to deliver precise in vivo cell engineering

https://pharmaphorum.com/news/capstantx-secures-165-million-to-deliver-precise-in-vivo-cell-engineering/

Ensure Long-Term Patient Safety & Potency of Your LNP

Lipid Nanoparticles Immunogenicity & Toxicity | December 6-8, 2022

https://pharmaphorum.com/events/lipid-nanoparticles-immunogenicity-toxicity-december-6-8-2022/

Optimise LNP Formulation & Process Development

Lipid Nanoparticles Development Summit Europe | 18th – 20th October, 2022

https://pharmaphorum.com/events/lipid-nanoparticles-development-summit-europe-18th-20th-october-2022/

Harness Safe & Efficacious Lipid-Based Delivery for Novel Therapeutics Beyond RNA & Hepatic Tissue The recent success of

Next Generation Lipid-Based Nanoparticles Delivery Summit | July 19-21, 2022

https://pharmaphorum.com/events/next-generation-lipid-based-nanoparticles-delivery-summit-july-19-21-2022/

Embrace Technology Innovations to Optimise LNP Formulation, Alternative LNP Raw Materials, Process Control to Achieve Seamless Scale-Up, Compliance

LNP Formulation and Process Development in Pharma | April 12-14 2022

https://pharmaphorum.com/events/lnp-formulation-and-process-development-in-pharma-april-12-14-2022/

Lipid Nanoparticles